DESENHOS NARRATIVOS: WORKSHOP DO LABORATÓRIO TRANSDISCIPLINAR DE CENOGRAFIA (LTC) NA QUADRIENAL DE PRAGA DE 2019

This essay explores, through creative and collaborative writing in a Tramóia format, the Narrative Drawings project conducted by the Transdisciplinary Scenography Laboratory (LTC) – Continuous Action Extension Program of the University of Brasilia (UnB), created and coordinated by Profa. Dr. Sonia Paiva – for Prague Quadrennial (PQ) 2019. The workshop, featured in PQStudio's programming, is part of the laboratory repertoire which has been operating since 2010 to achieve one of its main goals: delivering multicultural and transdisciplinary experiences to the public as a result of constant deeds that interconnect research and actions of the laboratory. Throughout the dialogues of the Tramóia, themes related to the project are addressed: LTC creation and production dynamics, relation and perception of the spectator, group concepts and metaphors, among others. Keywords Weft. Design. Collaboration. Transdisciplinarity. Ethnomathematics.O presente ensaio explora, por meio de uma escrita criativa e colaborativa em formato de Tramóia, o projeto Desenhos Narrativos realizado pelo Laboratório Transdisciplinar de Cenografia (LTC) – Programa de Extensão de Ação Contínua (PEAC) da Universidade de Brasília (UnB), criado e coordenado pela Profa. Dra. Sonia Paiva – para Quadrienal de Praga (PQ) de 2019. O workshop, apresentado na programação da PQStudio, compõe parte do repertorio do laboratório que opera, desde de 2010, visando atingir uma de suas principais metas: entregar para o público experiências multiculturais e transdisciplinares, vindas das ações constantes que interconectam as pesquisas e práticas do laboratório. Ao longo dos diálogos da tramóia são abordados temas relacionados ao projeto: dinâmicas de criação e produção do LTC, relação e percepção do público, conceitos e metáforas do grupo, dentre outras. Palavras-chave Trama. Desenho. Colaboração. Transdisciplinaridade. Etnomatemática

Cimicifuga racemosa: terapia alternativa para o climatério / Cimicifuga racemosa: alternative therapy for climacteric

O artigo correlaciona a fitoterapia com a saúde da mulher, objetivando esclarecer os benefícios e a importância dessa terapia alternativa, especialmente durante o climatério. Nesse caso, o enfoque foi o uso da Cimicifuga racemosa para alívio dessas manifestações, como os fogachos, previamente submetidas à análise médica. Para isso, a metodologia contemplou a busca nas bases de dados Scientific Eletronic Library Online (Scielo), Biblioteca Virtual em Saúde (BVS), National Center for Biotechnology Information (PubMed), sendo excluídos os artigos que não contemplavam a metodologia de busca. Os resultados apontaram para a eficácia do uso, especialmente, considerando as amplas possibilidades de sintomas, bem como os riscos da terapia de reposição hormonal tradicional. Portanto, conclui-se a importância das práticas alternativas e complementares na manutenção da saúde da mulher

Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors

Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the 2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed

Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET

Hemangiosarcoma is a mesenchymal neoplasm originating in the endothelial cells of blood vessels; they can be classified as non-visceral and visceral types. Non-visceral hemangiosarcomas can affect the skin, subcutaneous tissues, and muscle tissues; visceral hemangiosarcomas can affect the spleen, liver, heart, lungs, kidneys, oral cavity, bones, bladder, uterus, tongue, and retroperitoneum. Among domestic species, dogs are most affected by cutaneous HSA. Cutaneous HSA represents approximately 14% of all HSA diagnosed in this species and less than 5% of dermal tumors, according to North American studies. However, Brazilian epidemiological data demonstrate a higher prevalence, which may represent 27 to 80% of all canine HSAs and 13.9% of all skin neoplasms diagnosed in this species. Cutaneous HSA most commonly affects middle-aged to elderly dogs (between 8 and 15 years old), with no gender predisposition for either the actinic or non-actinic forms. The higher prevalence of cutaneous HSA in some canine breeds is related to lower protection from solar radiation, as low skin pigmentation and hair coverage lead to greater sun exposure. Actinic changes, such as solar dermatosis, are frequent in these patients, confirming the influence of solar radiation on the development of this neoplasm. There are multiple clinical manifestations of hemangiosarcoma in canines. The diagnostic approach and staging classification of cutaneous HSAs are similar between the different subtypes. The definitive diagnosis is obtained through histopathological analysis of incisional or excisional biopsies. Cytology can be used as a presurgical screening test; however, it has little diagnostic utility in cases of HSA because there is a high risk of blood contamination and sample hemodilution. Surgery is generally the treatment of choice for dogs with localized non-visceral HSA without evidence of metastatic disease. Recently, electrochemotherapy (ECT) has emerged as an alternative therapy for the local ablative treatment of different neoplastic types; the use of radiotherapy for the treatment of dogs with cutaneous HSA is uncommon. There is greater consensus in the literature regarding the indications for adjuvant chemotherapy in subcutaneous and muscular HSA; doxorubicin is the most frequently used antineoplastic agent for subcutaneous and muscular subtypes and can be administered alone or in combination with other drugs. Other therapies include antiangiogenic therapy, photodynamic therapy, the association of chemotherapy with the metronomic dose, targeted therapies, and natural products. The benefits of these therapies are presented and discussed. In general, the prognosis of splenic and cardiac HSA is unfavorable. As a challenging neoplasm, studies of new protocols and treatment modalities are necessary to control this aggressive disease